What's Going On With Pfizer Stock Thursday?
AC Immune Stock Climbs 7% on FDA Fast Track Status for Alzheimer's Drug
Pfizer Hemophilia B Gene Therapy Durveqtix Wins EC Authorization
Pfizer's Options: A Look at What the Big Money Is Thinking
Looking Into Johnson & Johnson's Recent Short Interest
AbbVie Raises Outlook as New Immunology Drugs Offset Humira Impact
Zoetis Analyst Ratings
Viking Sends Lilly, Novo Lower as Obesity Drug Enters Late-stage Program
Newly-Listed Psoriasis Alumis Attracts Analysts' Attention With Promising Lead Program And Modest Valuation
Pfizer/ BioNTech Win U.K. Nod for JN.1-adjusted COVID-19 Shot
Bio-Thera Biosimilar to J&J's Stelara Under FDA Review
Sangamo Stock Spikes As Pfizer Partnership Meets Goal In Late-Stage Study
Check Out What Whales Are Doing With JNJ
Jim Cramer Calls Axsome A 'Double Or Nothing Stock,' Says SAP Is 'Incredible'
Pfizer/ Sangamo Gene Therapy for Hemophilia A Succeeds in Late-stage Trial
Novo Nordisk's Stock Dips In Pre-Market Despite Winning UK's Approval Of Weight Loss Drug: What's Going On
Merck Competes With Sanofi/AstraZeneca As Its RSV Treatment Drug Meets Primary Goal In Late-Stage Study In Infants
Pfizer And GSK's ViiV Healthcare's Two-Drug HIV Treatment Matches Gilead's Three-Drug Combo In Major Trial
10 Health Care Stocks Whale Activity In Today's Session
Pharma Giant Johnson & Johnson Asks FDA To Approve Esketamine Nasal Spray For Treatment-Resistant Depression